Critical Limb Ischemia Global Clinical Trials Review, H1, 2012 - New Study Released

July 4, 2012 - PRLog -- GlobalData's clinical trial report, "Critical Limb Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/405046_critical_limb_ischemia_global_clinical_trials.aspx
------------------------------------------------------------

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
* Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
* Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

* Understand the dynamics of a particular indication in a condensed manner
* Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
* Obtain discontinued trial listing for trials across the globe
* Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Critical Limb Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Critical Limb Ischemia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Partial Table of Contents:

Table of Contents
List of Tables
List of Figures
Introduction
Critical Limb Ischemia
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Critical Limb Ischemia
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Critical Limb Ischemia Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Stempeutics Research Private Limited
Clinical Trial Overview of Stempeutics Research Private Limited
Pluristem Therapeutics Inc.
Clinical Trial Overview of Pluristem Therapeutics Inc.
Medistem, Inc.
Clinical Trial Overview of Medistem, Inc.
TCA Cellular Therapy, LLC
Clinical Trial Overview of TCA Cellular Therapy, LLC
Juventas Therapeutics, Inc.
Clinical Trial Overview of Juventas Therapeutics, Inc.
AnGes MG, Inc.
Clinical Trial Overview of AnGes MG, Inc.
ViroMed Co., Ltd.
Clinical Trial Overview of ViroMed Co., Ltd.
Aastrom Biosciences, Inc.
Clinical Trial Overview of Aastrom Biosciences, Inc.
Salus Pharmaceuticals Pvt. Ltd.
Clinical Trial Overview of Salus Pharmaceuticals Pvt. Ltd.
BI BIOTECH INDIA PRIVATE LIMITED
Clinical Trial Overview of BI BIOTECH INDIA PRIVATE LIMITED
Harvest Pharmaceuticals Inc
Clinical Trial Overview of Harvest Pharmaceuticals Inc
Bayer AG
Clinical Trial Overview of Bayer AG
HyperMed, Inc.
Clinical Trial Overview of HyperMed, Inc.
Aldagen, Inc.
Clinical Trial Overview of Aldagen, Inc.
MultiGene Vascular Systems (MGVS) Ltd.
Clinical Trial Overview of MultiGene Vascular Systems (MGVS) Ltd.
Sangart, Inc.
Clinical Trial Overview of Sangart, Inc.
W. L. Gore & Associates, Inc.
Clinical Trial Overview of W. L. Gore & Associates, Inc.
United Therapeutics Corporation
Clinical Trial Overview of United Therapeutics Corporation
Biotronik SE & Co. KG
Clinical Trial Overview of Biotronik SE & Co. KG
Covidien plc
Clinical Trial Overview of Covidien plc
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Flanders Medical Research Program
Clinical Trial Overview of Flanders Medical Research Program
Northwestern University
Clinical Trial Overview of Northwestern University
CHU de Reims
Clinical Trial Overview of CHU de Reims
Kansai Rosai Hospital
Clinical Trial Overview of Kansai Rosai Hospital
Institute of Biomedical Research and Innovation
Clinical Trial Overview of Institute of Biomedical Research and Innovation
Baylor Research Institute
Clinical Trial Overview of Baylor Research Institute
The Center of Nutrigenomics of the Technical University Munich

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4050...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.